Insider · CIK 0001752965
O'Connell Daniel P
Reports to the SEC for 1 company · CAMBRIDGE
Transactions
9
Companies
1
Filings
5
CIK
0001752965
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2020-12-10 | LogicBio Therapeutics, Inc.M Exercise/Conversion | — |
| 2020-12-10 | LogicBio Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2020-06-19 | LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2020-06-19 | LogicBio Therapeutics, Inc.Restricted Stock UnitsA Award | — |
| 2019-12-19 | LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2018-10-23 | LogicBio Therapeutics, Inc.C Conversion | — |
| 2018-10-23 | LogicBio Therapeutics, Inc.P Purchase | +$7M |
| 2018-10-23 | LogicBio Therapeutics, Inc.Series B Convertible Preferred StockC Conversion | — |
| 2018-10-18 | LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award | — |
Recent filings
- 4O'Connell Daniel P0000899243-20-033801SEC(opens sec.gov)
- 4O'Connell Daniel P0001209191-20-038667SEC(opens sec.gov)
- 4O'Connell Daniel P0001209191-19-061666SEC(opens sec.gov)
- 4O'Connell Daniel P0000899243-18-027477SEC(opens sec.gov)
- 4O'Connell Daniel P0000899243-18-027231SEC(opens sec.gov)
Companies
Address
C/O LOGICBIO THERAPEUTICS, INC. 610 MAIN ST., 3RD FLOOR
CAMBRIDGE, 02139